Zoll AED Plus Receives EU MDR Certification
The Zoll AED Plus defibrillator is now approved under the European Union (EU) Medical Device Regulation 2017/745, commonly referred to as EU MDR, according to the company.
The Zoll AED Plus defibrillator is now approved under the European Union (EU) Medical Device Regulation 2017/745, commonly referred to as EU MDR, according to the company.
The Zoll AED Plus defibrillator is now approved under the European Union (EU) Medical Device Regulation 2017/745, commonly referred to as EU MDR, according to the company.
Read MoreResearchers say the data similarities between states with AED mandates and those without suggest that improving bystander AED use will need to go beyond legislative measures.
Read MoreThe Zoll AED 3Â defibrillator is approved under the European Union (EU) Medical Device Regulation 2017/745, commonly referred to as EU MDR, according to the company.
Read MoreBystander AED use for a cardiac arrest victim improved 30-day survival even with ambulance response times as short as two minutes, according to research presented at ESC Congress 2023.
Read MoreRT looks at the latest resuscitation devices on the market from manufacturers like Dynarex, Flexicare, and Mercury Medical.
Read MoreThe Cleveland Browns and University Hospitals are distributing automated external defibrillators and CPR training to area high schools.
Read MoreThe Avive AED, a 2.1-lb handheld automated external defibrillator, has received US FDA pre-market approval, according to manufacturer Avive Solutions Inc.
Read MoreNew high-power charging stations for electric vehicles have the potential to create strong electromagnetic fields and cause electromagnetic interference in pacemakers and defibrillators, leading them to malfunction.
Read MoreDrones were able to deliver AEDs to suspected cardiac arrest victims in residential areas approximately two minutes faster than an ambulance, according to a feasibility study at ESC 2021.
Read MoreZoll AED 3Â and Zoll AED 3 BLS automated external defibrillators (AEDs) were recognized by the World of Safety & Health Asia (WSHAsia) in its inaugural New & Innovative Solutions Awards program.
Read MoreThe Philips Tempus ALS combines a remote portable vital signs patient monitor (Tempus Pro), and remote professional defibrillator (Tempus LS-Manual).
Read MoreZoll launched its new remote view technology on the X Series monitor/defibrillator developed for EMS agencies, according to the company.
Read MoreThe FDA has granted premarket approval for the Philips HeartStart FR3 and HeartStart FRx automated external defibrillators, and their supporting accessories, including batteries and pads.
Read MoreZoll Medical Corp has received premarket approval (PMA) from the FDA for the Zoll AED 3 defibrillator to be used by lay rescuers, according to the company.
Read MorePhilips reports that its Emergency Care and Resuscitation business is resuming manufacturing and shipping of external defibrillators for the US.
Read MoreThe Spanish Football Association (AFE) has equipped the stadiums and training fields of its 617 football clubs with Zoll AED Plus automated external defibrillators, according to Zoll Medical.
Read MoreZoll Medical Corp has signed a definitive agreement to purchase Cardiac Science Corporation (CSC), a leading provider of automated external defibrillators.
Read MoreInformation on resuscitation devices from leading manufacturers Zoll, Vortran, and more.
Read MoreRT looks into the latest product advances in ALS defibrillators and monitors used in the ICU, EMS pre-hospital, and other clinical settings.
Read MoreThe FDA has classified the recall of over 47,000 Philips HeartStart MRx Monitor/Defibrillators as a Class I recall.
Read MoreThe Zoll HWD is designed to continuously protect patients at risk of ventricular tachycardia or ventricular fibrillation during hospitalization.
Read MoreAutomated external defibrillators (AEDs) are life-saving medical devices, and yet access to them during a cardiac arrest is significantly limited.
Read MoreThe FDA has approved a new indication for Zoll Corp’s LifeVest wearable cardioverter defibrillator, which can now be prescribed for certain pediatric patients at risk of sudden cardiac arrest.
Read MoreA new group of resuscitation devices are demonstrating that there is always room for improvement.
Read More